203 related articles for article (PubMed ID: 26590194)
1. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
Karol SE; Mattano LA; Yang W; Maloney KW; Smith C; Liu C; Ramsey LB; Fernandez CA; Chang TY; Neale G; Cheng C; Mardis E; Fulton R; Scheet P; San Lucas FA; Larsen EC; Loh ML; Raetz EA; Hunger SP; Devidas M; Relling MV
Blood; 2016 Feb; 127(5):558-64. PubMed ID: 26590194
[TBL] [Abstract][Full Text] [Related]
2. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
[TBL] [Abstract][Full Text] [Related]
3. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.
den Hoed MA; Pluijm SM; Uitterlinden AG; Pieters R; van den Heuvel-Eibrink MM
Mol Diagn Ther; 2016 Dec; 20(6):519-522. PubMed ID: 27365083
[TBL] [Abstract][Full Text] [Related]
4. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
[No Abstract] [Full Text] [Related]
5. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
[TBL] [Abstract][Full Text] [Related]
6. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
Yang W; Devidas M; Liu Y; Smith C; Dai Y; Winick N; Hunger SP; Loh ML; Raetz EA; Larsen EC; Carroll WL; Winter SS; Dunsmore KP; Mattano LA; Relling MV; Karol SE
Blood; 2021 Mar; 137(11):1550-1552. PubMed ID: 33106839
[No Abstract] [Full Text] [Related]
7. Investigation of the Relationship Between
Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
[TBL] [Abstract][Full Text] [Related]
8. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
[TBL] [Abstract][Full Text] [Related]
9. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
10. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.
Archer NP; Perez-Andreu V; Scheurer ME; Rabin KR; Peckham-Gregory EC; Plon SE; Zabriskie RC; De Alarcon PA; Fernandez KS; Najera CR; Yang JJ; Antillon-Klussmann F; Lupo PJ
Cancer; 2016 Dec; 122(23):3697-3704. PubMed ID: 27529658
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
[No Abstract] [Full Text] [Related]
13. Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP).
Parasole R; Valsecchi MG; Silvestri D; Locatelli F; Barisone E; Petruzziello F; Putti MC; Micalizzi C; Colombini A; Mura R; Mina T; Testi AM; Notarangelo LD; Santoro N; Casini T; Consarino C; Nigro LL; Ziino O; Giagnuolo G; Rizzari C; Conter V
Blood Cancer J; 2018 Nov; 8(12):115. PubMed ID: 30442887
[No Abstract] [Full Text] [Related]
14. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
15. Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.
Karol SE; Larsen E; Cheng C; Cao X; Yang W; Ramsey LB; Fernandez CA; McCorkle JR; Paugh SW; Autry RJ; Lopez-Lopez E; Diouf B; Jeha S; Pui CH; Raetz EA; Winick NJ; Carroll WL; Hunger SP; Loh ML; Devidas M; Evans WE; Yang JJ; Relling MV
Leukemia; 2017 Jun; 31(6):1325-1332. PubMed ID: 28096535
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
[TBL] [Abstract][Full Text] [Related]
17. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
19. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Badhiwala JH; Nayiager T; Athale UH
Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]